查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
耳鼻喉設備市場：按產品、最終用戶分類，預測 2023-2032 年
市場調查報告書
商品編碼
1264992

耳鼻喉設備市場：按產品、最終用戶分類，預測 2023-2032 年

ENT Devices Market - By Product, By End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 330 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在耳鼻喉設備技術創新進步的推動下，預計到 2032 年全球耳鼻喉設備市場將實現顯著增長。

此外，該領域的參與者專注於設計具有集成功能的助聽器，幫助用戶跟蹤他們的認知聽力。 例如，2022 年 11 月，醫療設備公司 Cochlear 將為其 Nucleus 8 聲音處理器（最小的耳後式人工耳蝸聲音處理器）提供與日常消費電子產品的直接藍牙連接，並獲得美國 FDA 批准。

總體而言，耳鼻喉設備行業根據產品、最終用途和地理位置進行細分。

按產品劃分，耳鼻喉科手術設備市場將增長預計到 2020 年將實現顯著增長。 據美國癌症協會估計，僅在 2023 年，美國就將診斷出約 54,540 例口咽癌新病例。 此外，圖像引導手術系統等手術設備的最新進展擴大了它們在耳鼻喉科的應用，為細分市場的增長提供了有利可圖的機會。

由於對先進手術和診斷的需求不斷增長，預計到 2032 年，耳鼻喉診所領域的耳鼻喉設備行業的最終用途估值將超過 70 億美元。事實一直如此。 這些設施配備了先進的診斷設備和熟練的醫務人員，導致患者人數不斷增加。 此外，世界各國政府都在大力投資耳鼻喉科診所，這也推動了該行業的增長。

按地區劃分，歐洲耳鼻喉設備市場到 2022 年將超過 60 億美元。 耳鼻喉疾病的日益流行增加了該地區對耳鼻喉設備的需求。 據世衛組織稱，世衛組織歐洲區域有超過 1.9 億人患有不同程度的聽力損失。

此外，Sonova Holding AG 和 Lumenis Be Ltd 等主要行業領導者不斷致力於新產品創新，進一步推動區域擴張。 例如，2023 年 1 月，瑞士聽力保健解決方案提供商 Sonova Holding AG 將推出 Sennheiser Conversation Clear Plus 耳塞，這是一種全新的語音增強耳戴式解決方案，可幫助用戶提高在嘈雜環境中的理解力。 通過這次發布，該公司建立了一個新的早期進入者聽力解決方案類別。

內容

第一章調查方法及範圍

第 2 章執行摘要

第 3 章：耳鼻喉設備行業洞察

  • 行業格局，2018-2032 年版
  • 影響行業的因素
    • 司機
      • 耳鼻喉疾病的全球流行率上升
      • 全球老齡化人口不斷增加
      • 耳鼻喉科設備技術進步
      • 對微創耳鼻喉科手術的需求不斷增長
    • 行業潛在的風險和挑戰
      • 高昂的程序和設備成本
      • 世界各地的社會恥辱
  • 增長分析
    • 按產品類型
    • 按最終用途
  • COVID-19 影響分析
  • 監管狀況
    • 美國
    • 歐洲
  • 技術概況
  • 贖回場景
    • 美國
    • 歐洲
  • 未來的市場趨勢
  • 差距分析
  • 價值鏈分析
  • 波特分析
  • PESTEL 分析

第 4 章競爭格局，2022 年

  • 簡介
  • 公司矩陣分析，2022 年
  • 戰略儀表板，2022 年

第 5 章耳鼻喉設備市場，按產品類型分類

  • 主要產品類型的趨勢
  • 耳鼻喉科診斷設備
    • 硬性內窺鏡
      • 鼻窺鏡
      • 會厭範圍
      • 耳鼻喉科內窺鏡
    • 軟性內窺鏡
    • 機器人輔助內窺鏡
    • 聽力篩查設備
  • 耳鼻喉科手術器械
    • 無線電波手機
    • 電動手術器械
    • 耳科鑽孔器
    • 耳鼻喉手持器械
    • 鼓膜切開管
    • 鼻竇擴張器
    • 鼻腔填塞裝置
  • 助聽器
    • 年度最佳 (BTE)
    • 在運河中完成/在運河中隱形 (CIC/IIC)
    • 在運河 (ITC)
    • 年度 (ITE)
    • 耳式接收器/耳道式接收器 (RITE/RIC)
  • 聽力障礙植入物
    • 聽覺腦幹植入物
    • 人工耳蝸
    • 中耳植入物
    • 骨錨式助聽器
  • 語音合成設備
  • 鼻夾板
    • 鼻內夾板
    • 外鼻夾板

第 6 章 ENT 設備市場：按最終用戶分類

  • 主要的最終用戶趨勢
  • 醫院
  • 門診手術中心 (ASC)
  • 耳鼻喉科診所
  • 家庭護理

第 7 章 ENT 設備市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 波蘭
    • 瑞典
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 印度尼西亞
    • 菲律賓
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 土耳其人
    • 埃及

第八章公司簡介

  • DeSoutter Medical
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet
  • Olympus Corporation
  • WestCMR
  • Smith & Nephew plc
  • Nouvag AG
  • Vega Medical
  • Atos Medical
  • Boston Scientific Corporation
  • Cochlear
  • Lumenis Be Ltd
  • Meril Life Sciences Pvt. Ltd
  • Narang Medical Limited.
  • Sonova Group
  • Welch Allyn
簡介目錄
Product Code: 496

Global ENT devices market is slated to record substantial gains through 2032, pushed by the growing technological innovations in ENT devices. Moreover, players in the field have been focusing on devising hearing aids with integration capabilities to help users track their cognitive hearing. Citing an instance, in November 2022, Cochlear, a medical device company, received U.S. FDA clearance for its Nucleus® 8 Sound Processor, the smallest behind-the-ear cochlear implant sound processor, offering direct connectivity to daily consumer electronics via Bluetooth.

Overall, the ENT devices industry is segmented in terms of product, end-use, and region.

On the basis of product, the ENT devices market from the surgical ENT devices segment is poised to register noteworthy gains through 2032, owing to the growing occurrence of ENT disorders such as oral cancer, temporal bone cancer, and others that require surgeries for treatment. As per the American Cancer Society, in 2023, around 54,540 new cases of oropharyngeal cancer are estimated to be diagnosed in the U.S. alone. Furthermore, recent advancements in surgical equipment, such as image-guided surgery systems, have increased their applications in otorhinolaryngology, presenting lucrative opportunities for segment growth.

In terms of end-use, the ENT devices industry from the ENT clinics segment is anticipated to record a valuation of over USD 7 billion by 2032 on account of rising demand for advanced surgical and diagnostic procedures. These facilities also have strong availability of advanced diagnostic devices and skilled healthcare professionals resulting in increased patient footfall. Moreover, governments across the globe are investing ample amounts in ENT clinics, which is further set to augment segment growth.

From the regional perspective, the Europe ENT devices market garnered over USD 6 billion in 2022. The growing prevalence of ENT disorders has accentuated the need for ENT devices in the region. As per WHO, more than 190 million people in the WHO European Region have some degree of hearing loss.

Moreover, the robust presence of major industry leaders such as Sonova Holding AG, Lumenis Be Ltd, and others constantly indulging in innovating new products is also fueling regional expansion. For instance, in January 2023, Sonova Holding AG, a Swiss hearing care solutions provider, announced the launch of Sennheiser Conversation Clear Plus earbuds, new speech-enhanced hearable solutions to help users improve their comprehension in loud environments. This launch helped the company establish a new category of early-entry hearing solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 ENT devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product type trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 ENT Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of ENT disorders globally
      • 3.2.1.2 Increasing geriatric population globally
      • 3.2.1.3 Technological advancements in the ENT devices
      • 3.2.1.4 Rising demand for minimally invasive ENT procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedure and instruments cost
      • 3.2.2.2 Social stigma across the globe
  • 3.3 Growth potential analysis
    • 3.3.1 By product type
    • 3.3.2 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Technology landscape
  • 3.7 Reimbursement scenario
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Future market trends
  • 3.9 Gap analysis
  • 3.10 Value-chain analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Strategy dashboard, 2022

Chapter 5 ENT Devices Market, By Product Type

  • 5.1 Key product type trends
  • 5.2 Diagnostic ENT Devices
    • 5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.2 Rigid Endoscopes
      • 5.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.2 Rhinoscopes
        • 5.2.2.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.3 Laryngoscopes
        • 5.2.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
      • 5.2.2.4 Otological Endoscopes
        • 5.2.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.3 Flexible Endoscopes
      • 5.2.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.4 Robot Assisted Endoscopes
      • 5.2.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.2.5 Hearing Screening Device
      • 5.2.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.3 Surgical ENT Devices
    • 5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.2 Radiofrequency Handpieces
      • 5.3.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.3 Powered Surgical Instrument
      • 5.3.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.4 Otological Drill Burrs
      • 5.3.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.5 ENT Hand Instruments
      • 5.3.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.6 Tympanostomy Tubes
      • 5.3.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.7 Sinus Dilation Devices
      • 5.3.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.3.8 Nasal Packing Devices
      • 5.3.8.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.4 Hearing Aids
    • 5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.2 Behind-the-ear (BTE)
      • 5.4.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.3 Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
      • 5.4.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.4 In-the-canal (ITC)
      • 5.4.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.5 In-the-ear (ITE)
      • 5.4.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.4.6 Receiver in the ear/Receiver in Canal (RITE/RIC)
      • 5.4.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.5 Hearing Implants
    • 5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.2 Auditory Brainstem Implants
      • 5.5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.3 Cochlear Implants
      • 5.5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.4 Middle Ear Iimplants
      • 5.5.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.5.5 Bone Anchored Hearing System
      • 5.5.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.6 Voice Prosthesis Devices
    • 5.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 5.7 Nasal Splints
    • 5.7.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.7.2 Internal Nasal Splints
      • 5.7.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
    • 5.7.3 External Nasal Splints
      • 5.7.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 6 ENT Devices Market, By End-use

  • 6.1 Key end-use trends
  • 6.2 Hospitals
    • 6.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.3 Ambulatory surgical centers (ASCs)
    • 6.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.4 ENT Clinics
    • 6.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
  • 6.5 Homecare
    • 6.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)

Chapter 7 ENT Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Poland
    • 7.3.7 Sweden
    • 7.3.8 The Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Philippines
    • 7.4.8 Vietnam
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Columbia
    • 7.5.5 Chile
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Israel
    • 7.6.5 Turkey
    • 7.6.6 Egypt

Chapter 8 Company Profiles

  • 8.1 DeSoutter Medical
  • 8.2 Johnson & Johnson
  • 8.3 Medtronic plc
  • 8.4 Stryker Corporation
  • 8.5 Zimmer Biomet
  • 8.6 Olympus Corporation
  • 8.7 WestCMR
  • 8.8 Smith & Nephew plc
  • 8.9 Nouvag AG
  • 8.10 Vega Medical
  • 8.11 Atos Medical
  • 8.12 Boston Scientific Corporation
  • 8.13 Cochlear
  • 8.14 Lumenis Be Ltd
  • 8.15 Meril Life Sciences Pvt. Ltd
  • 8.16 Narang Medical Limited.
  • 8.17 Sonova Group
  • 8.18 Welch Allyn